Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
Alzheimer’s disease (AD) is a disorder that causes degeneration of the cells in the brain and it is the main cause of dementia, which is characterized by a decline in thinking and independence in personal daily activities. AD is considered a multifactorial disease: two main hypotheses were proposed as a cause for AD, cholinergic and amyloid hypotheses. Additionally, several risk factors such as increasing age, genetic factors, head injuries, vascular diseases, infections, and environmental factors play a role in the disease. Currently, there are only two classes of approved drugs to treat AD, including inhibitors to cholinesterase enzyme and antagonists to N-methyl d-aspartate (NMDA), which are effective only in treating the symptoms of AD, but do not cure or prevent the disease. Nowadays, the research is focusing on understanding AD pathology by targeting several mechanisms, such as abnormal tau protein metabolism, β-amyloid, inflammatory response, and cholinergic and free radical damage, aiming to develop successful treatments that are capable of stopping or modifying the course of AD. This review discusses currently available drugs and future theories for the development of new therapies for AD, such as disease-modifying therapeutics (DMT), chaperones, and natural compounds.
Top-30
Journals
|
10
20
30
40
50
60
70
80
|
|
|
International Journal of Molecular Sciences
78 publications, 4.02%
|
|
|
Journal of Alzheimer's Disease
45 publications, 2.32%
|
|
|
Molecular Neurobiology
33 publications, 1.7%
|
|
|
Frontiers in Aging Neuroscience
30 publications, 1.55%
|
|
|
Molecules
27 publications, 1.39%
|
|
|
Ageing Research Reviews
26 publications, 1.34%
|
|
|
Biomedicines
24 publications, 1.24%
|
|
|
Scientific Reports
21 publications, 1.08%
|
|
|
Frontiers in Pharmacology
20 publications, 1.03%
|
|
|
Antioxidants
17 publications, 0.88%
|
|
|
Brain Sciences
17 publications, 0.88%
|
|
|
Pharmaceutics
16 publications, 0.83%
|
|
|
Biomolecules
16 publications, 0.83%
|
|
|
ACS Chemical Neuroscience
16 publications, 0.83%
|
|
|
Journal of Molecular Structure
15 publications, 0.77%
|
|
|
Cureus
14 publications, 0.72%
|
|
|
Pharmaceuticals
13 publications, 0.67%
|
|
|
Frontiers in Neuroscience
13 publications, 0.67%
|
|
|
Cells
13 publications, 0.67%
|
|
|
Frontiers in Neurology
12 publications, 0.62%
|
|
|
Biomedicine and Pharmacotherapy
12 publications, 0.62%
|
|
|
Neuroscience
12 publications, 0.62%
|
|
|
Brain Research
12 publications, 0.62%
|
|
|
International Journal of Biological Macromolecules
12 publications, 0.62%
|
|
|
Life
11 publications, 0.57%
|
|
|
PLoS ONE
11 publications, 0.57%
|
|
|
Nutrients
10 publications, 0.52%
|
|
|
Journal of Biomolecular Structure and Dynamics
10 publications, 0.52%
|
|
|
Heliyon
9 publications, 0.46%
|
|
|
10
20
30
40
50
60
70
80
|
Publishers
|
50
100
150
200
250
300
350
400
450
|
|
|
Elsevier
421 publications, 21.72%
|
|
|
Springer Nature
363 publications, 18.73%
|
|
|
MDPI
338 publications, 17.44%
|
|
|
Frontiers Media S.A.
131 publications, 6.76%
|
|
|
Wiley
126 publications, 6.5%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
63 publications, 3.25%
|
|
|
Taylor & Francis
60 publications, 3.1%
|
|
|
SAGE
59 publications, 3.04%
|
|
|
Cold Spring Harbor Laboratory
45 publications, 2.32%
|
|
|
Bentham Science Publishers Ltd.
43 publications, 2.22%
|
|
|
American Chemical Society (ACS)
41 publications, 2.12%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
23 publications, 1.19%
|
|
|
Royal Society of Chemistry (RSC)
18 publications, 0.93%
|
|
|
Oxford University Press
14 publications, 0.72%
|
|
|
Hindawi Limited
14 publications, 0.72%
|
|
|
Public Library of Science (PLoS)
12 publications, 0.62%
|
|
|
Walter de Gruyter
8 publications, 0.41%
|
|
|
King Saud University
7 publications, 0.36%
|
|
|
Pleiades Publishing
6 publications, 0.31%
|
|
|
Hans Publishers
5 publications, 0.26%
|
|
|
Georg Thieme Verlag KG
4 publications, 0.21%
|
|
|
IOP Publishing
4 publications, 0.21%
|
|
|
IMR Press
4 publications, 0.21%
|
|
|
IOS Press
3 publications, 0.15%
|
|
|
SciELO
3 publications, 0.15%
|
|
|
Association for Computing Machinery (ACM)
3 publications, 0.15%
|
|
|
Mark Allen Group
3 publications, 0.15%
|
|
|
Institution of Engineering and Technology (IET)
3 publications, 0.15%
|
|
|
The Korean Society for Biomedical Laboratory Sciences
3 publications, 0.15%
|
|
|
50
100
150
200
250
300
350
400
450
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.